Back
Corcept Therapeutics Stock Price Chart
Should You Invest in this AI Marketing High-Growth Startup by April?
Invest Now & Secure Your Stake in RAD Intel
Sell
45
CORT
Corcept Therapeutics
Last Price:
$55.44
Seasonality Move:
9.53%
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Dreams, Mode Mobile Delivers
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CORT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Corcept Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.01 | Sell |
| 20-day SMA: | 64.41 | Sell |
| 50-day SMA: | 59.7 | Sell |
| 200-day SMA: | 45.62 | Buy |
| 8-day EMA: | 57.96 | Sell |
| 20-day EMA: | 61.26 | Sell |
| 50-day EMA: | 60.34 | Sell |
| 200-day EMA: | 48.35 | Buy |
Corcept Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.88 | Sell |
| Relative Strength Index (14 RSI): | 36.47 | Sell |
| Chaikin Money Flow: | 837413 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (59.25 - 70.91) | Sell |
| Bollinger Bands (100): | (49.51 - 63.61) | Sell |
Corcept Therapeutics Technical Analysis
| Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | Mar | |||||||||
| 21 | 25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Corcept Therapeutics Stock
Is Corcept Therapeutics Stock a Buy?
-
Corcept Therapeutics share price is 55.40 while CORT 8-day simple moving average is 58.01, which is a Sell signal.
-
The stock price of CORT is 55.40 while Corcept Therapeutics 20-day SMA is 64.41, which makes it a Sell.
-
Corcept Therapeutics 50-day simple moving average is 59.70 while CORT share price is 55.40, making it a Sell technically.
-
CORT stock price is 55.40 and Corcept Therapeutics 200-day simple moving average is 45.62, creating a Buy signal.
CORT Technical Analysis vs Fundamental Analysis
Sell
45
Corcept Therapeutics (CORT)
is a Sell
Is Corcept Therapeutics a Buy or a Sell?
-
Corcept Therapeutics stock is rated a SellThe current Corcept Therapeutics [CORT] share price is $55.40. The Score for CORT is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Corcept Therapeutics Stock Info
Market Cap:
5.8B
Price in USD:
55.40
Share Volume:
1.4M
Corcept Therapeutics 52-Week Range
52-Week High:
75.00
52-Week Low:
20.84
Sell
45
Corcept Therapeutics (CORT)
is a Sell
Corcept Therapeutics Share Price Forecast
-
What is the Corcept Therapeutics stock price today?The Corcept Therapeutics stock price is 55.40 USD today.
-
Will CORT stock go up or go down?Corcept Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Corcept Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corcept Therapeutics is overvalued.
Is Corcept Therapeutics Stock a Buy?
-
Corcept Therapeutics share price is 55.40 while CORT 8-day exponential moving average is 57.96, which is a Sell signal.
-
The stock price of CORT is 55.40 while Corcept Therapeutics 20-day EMA is 61.26, which makes it a Sell.
-
Corcept Therapeutics 50-day exponential moving average is 60.34 while CORT share price is 55.40, making it a Sell technically.
-
CORT stock price is 55.40 and Corcept Therapeutics 200-day simple moving average is 48.35, creating a Buy signal.
Fundamental Analysis of Corcept Therapeutics
Is Corcept Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.50 per share, and an increase next year of $1.63 per share.
Technical Analysis of Corcept Therapeutics
Should I short Corcept Therapeutics stock?
-
CORT Moving Average Covergence Divergence (MACD) indicator is -1.88, suggesting Corcept Therapeutics is a Sell
-
Corcept Therapeutics Relative Strength Index (RSI) is 36.47, which suggest Corcept Therapeutics is oversold
-
The Bollinger Bands (25) for Corcept Therapeutics is (59.25 - 70.91), which suggest Corcept Therapeutics is a Sell
-
The Bollinger Bands (100) for Corcept Therapeutics is (49.51 - 63.61), which suggest Corcept Therapeutics is a Sell
* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.